Effigene Pharmaceuticals' Incubator/Accelerator Round

Effigene Pharmaceuticals raised a round of funding on , . Investors include Emtech Bio.

Effigene Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company developing small interference RNA (siRNA)-based therapeutics to treat various human diseases.…

Articles about Effigene Pharmaceuticals' Incubator/Accelerator Round: